| 000 | 01556 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517210541.0 | ||
| 264 | 0 | _c20190315 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1468-1331 | ||
| 024 | 7 |
_a10.1111/ene.13650 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFrau, J | |
| 245 | 0 | 0 |
_aPregnancy planning and outcomes in patients with multiple sclerosis after mitoxantrone therapy: a monocentre assessment. _h[electronic resource] |
| 260 |
_bEuropean journal of neurology _c08 2018 |
||
| 300 |
_a1063-1068 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAbortion, Spontaneous _xepidemiology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDisability Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFertility _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMitoxantrone _xadministration & dosage |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 | _aPatient Care Planning |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aPregnancy Outcome |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aTopoisomerase II Inhibitors _xadministration & dosage |
| 700 | 1 | _aCoghe, G | |
| 700 | 1 | _aCasanova, P | |
| 700 | 1 | _aSardu, C | |
| 700 | 1 | _aLorefice, L | |
| 700 | 1 | _aFenu, G | |
| 700 | 1 | _aMarrosu, M G | |
| 700 | 1 | _aCocco, E | |
| 773 | 0 |
_tEuropean journal of neurology _gvol. 25 _gno. 8 _gp. 1063-1068 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/ene.13650 _zAvailable from publisher's website |
| 999 |
_c28244865 _d28244865 |
||